Skip to main content
. 2020 Oct 6;11:573452. doi: 10.3389/fendo.2020.573452

Table 3.

Odds ratios and 95% confidence intervals for the association between MHO and hyperuricemia by sex.

ATP-III-based criteria Total (OR, 95% CI) Men (OR, 95% CI) Women (OR, 95% CI)
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
MHNW 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
MHOW 1.44 (1.15–1.8) 1.49 (1.18–1.87) 1.51 (1.15–1.99) 1.63 (1.23–2.15) 1.27 (0.84–1.91) 1.28 (0.84–1.93)
MHO 1.6 (1.04–2.47) 1.68 (1.08–2.6) 1.26 (0.69–2.28) 1.46 (0.8–2.68) 2.02 (1.063.85) 1.95 (1.023.74)
MUNW 3.22 (2.63–3.93) 2.37 (1.92–2.93) 2.48 (1.91–3.23) 1.74 (1.31–2.32) 4.24 (3.06–5.88) 3.34 (2.39–4.69)
MUOW 5.43 (4.49–6.55) 3.92 (3.21–4.78) 5.1 (4.02–6.46) 3.57 (2.77–4.6) 5.68 (4.12–7.84) 4.45 (3.2–6.2)
MUO 6.56 (5.2–8.28) 4.69 (3.66–6.01) 4.73 (3.44–6.5) 3.47 (2.46–4.91) 8.91 (6.23–12.74) 6.31 (4.33–9.18)

Data are presented as odds ratios (95% confidence intervals).

ATP-III, the Adult Treatment Panel-III; MHNW, metabolically healthy normal-weight; MHOW, metabolically healthy overweight; MHO, metabolically healthy obese; MUNO, metabolically unhealthy non-obese; MHO, metabolically healthy obese; MUNW, metabolically unhealthy normal-weight; MUOW, metabolically unhealthy overweight; and MUO, metabolically unhealthy obese. Model 1: Adjusted for age, urban/rural resident, smoking status, alcohol status, and metabolic health-obesity phenotypes. Model 2: Adjusted for Model 1+ white blood cell, total cholesterol, LDL-C, hsCRP and diabetes.

The bold values mean the results are significant for MHO groups.